That would be a fountain of many stories, yes. Guess it's in play for now.
This is not a big deal. Even at it's worst, a month isn't going to change the outcome of when he'll be ready. This is definitely creating anxiety where there doesn't need to be.
Peavy had a reattachment that was the same procedure done by the same surgeon as Reyes. Peavy was believed to be the first professional pitcher to have the surgery, and there was some unknown for him. In fact, coverage of the surgery referred to it as a "surgical first." Peavy was able to come back and pitch several more seasons, though he didn't as the same pitcher he was before the injury. He didn't have the same level of power, but he did have good seasons. Reyes' lat injury was not as severe or violent as Peavy's, but keep in mind Peavy's comments about the search for a surgeon and an answer, to Henry Schulman of The San Francisco Chronicle: "We certainly knew we were in uncharted waters," Peavy said. "We sought all kinds of medical opinions and did our research to see the history of lat injuries. There was some history, but never to the point of 100 percent being detached and retracted down to my back to where they would have to go get it and stitch it up, put some anchors in and reattach it."
These are good questions, the last few of which we don't have answers to because really Ankiel doesn't have those answers either, not this early in the process. The Cardinals are open to giving him the chance at spring training to be a lefty reliever that can help them. That means giving him innings, really. That's all. He'll come on a minor-league deal, and whether that means going to the minors will hinge entirely on how he pitches in spring, what the Cardinals' depth looks like in the Class AAA bullpen, and so on. Lots of unknowns there -- even for the pitcher himself. The Cardinals are intrigued, and at this point that's about as deep as any interest any team will have.
I don't think that will be the reason it ends, and I don't think it should be. What will bring the DH to the NL is money and leverage. The DH in the NL is a bargaining chip during the CBA and for expanded rosters and for more spending. Strategy won't dictate it.
Appears that way, yes. He has long predicted this move was coming.
Maybe. But not as important as talent.
If Paul Goldschmidt hits the trade market, he is, for sure. Pollock, is interesting. There's a good list. This free agent group has something for everybody. That's why it's so important that a team makes a move.
They think Hicks is their future closer. Kimbrel will not be on their radar.
It appears that he'll get a chance to play elsewhere. That could be via trade, maybe. That could be as a minor-league free agent in the coming weeks. That could be going abroad to make some good money and then slingshotting back to the majors. As mentioned, a handful of teams from Japan scouted him this winter.
Not sure what motivation the Diamondbacks would have to move Lamb unless it was for a significant package of players because he's not expensive, and he's under control for a few more years. I guess it depends on how deep a cut they intend to make into their teardown/tank.
That is true. They have not shown much interest in him. I have not yet heard anything that would suggest a change in that opinion. We'll see. That will be something to watch for coming into November and into the GM meetings because some clarity on how the Cardinals view/evaluate Moustakas would help us understand their shopping list.
Check back earlier in the chat. I was told -- and this has been mentioned before -- that the Cardinals did not "engage" in the pursuit of Scherzer, not with an offer that matched the hope of Scherzer when he was a free agent. The biggest reason was detailed earlier in the chat.
Draft lottery. International spending limits. Baseball operations spending floor.
Dallas Keuchel is a bit of a throwback pitcher. He leans heavily on an elite cutter, and sometimes that cutter can misbehave. He has to have movement to his pitches, and is a groundball monster with his cut/sink mix. So he's not going to go out there and blow past hitters or have a high total of strikeouts -- not at all. But he's going to get week contact, and he's going to put his defense to work (that would have to improve), and he absorbs strong innings and gives a rotation a different look from the left side. This is what I mean about the different costs of these two pitchers, Corbin and Keuchel. Corbin has the age, the stats, and the analytical sizzle to get him a big contract. Keuchel has the consistency that could make him a good buy over a shorter-term contract. He's got some staying power in the style that he uses as a pitcher, and with the exception of one recent year he's been an above average pitcher in a ballpark that can be dicey and in a league where he doesn't face the pitcher. These are traits that translate well to the NL. See: Hamels, Cole. And younger.
Here to stay. Not a fad. We're stuck with it. It's just extreme in October.
First, you described a pretty good player who has, yes, been undone by injury history, and you have to be aware of it. Second, he does several things well that contribute to a skill of not making outs. That's attractive. That's a good ability to have -- the ability to not make outs. I think a Cardinals team goes into a deal like that with eyes wide open in the sense that if you get 120 games, 130 games from Pollock you're a better team and there's Bader, Fowler, etc. to cover the remaining games. You're talking about an improvement in aggregate. This would be a much easier sell and a much higher likelihood if Pollock hit lefthanded. But he does a lot of things well that the Cardinals could benefit from. It's just he's not lefthanded.